Chronic condition

Responsum Health Launches Innovative Kidney Disease Information Platform

Thursday, May 28, 2020 - 2:00pm

WASHINGTON, May 28, 2020 /PRNewswire-PRWeb/ -- Today, Responsum Health (Responsum), an innovative developer of personalized patient apps and chronic disease knowledge communities, with support from Otsuka Pharmaceutical , a global healthcare company, announced the launch of an online connection and knowledge platform for patients with kidney disease, such as chronic kidney disease (CKD), a condition that affects an estimated 37 million Americans.

Key Points: 
  • WASHINGTON, May 28, 2020 /PRNewswire-PRWeb/ -- Today, Responsum Health (Responsum), an innovative developer of personalized patient apps and chronic disease knowledge communities, with support from Otsuka Pharmaceutical , a global healthcare company, announced the launch of an online connection and knowledge platform for patients with kidney disease, such as chronic kidney disease (CKD), a condition that affects an estimated 37 million Americans.
  • The platform, called Responsum for CKD , can be accessed for free via web browser or mobile app.
  • At its core, Responsum replaces unreliable web aggregators and social sites by providing patients and caregivers with a customized Newsfeed that has easy-to-read summaries of important kidney health news items.
  • Responsum also enables patients to better organize their health information, find local patient support groups and services, and support one another through a moderated, disease-specific social wall.

Livongo to Present at Upcoming Investor Conferences

Tuesday, May 26, 2020 - 2:00pm

Livongo empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health.

Key Points: 
  • Livongo empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health.
  • Livongo pioneered the category of Applied Health Signals to offer Members clinically-based insights that focus on the whole person and make it easier to stay healthy.
  • The Livongo approach delivers better clinical and financial outcomes while creating a different and better experience for people with chronic conditions.
  • For more information, visit: www.livongo.com or engage with Livongo on LinkedIn or Twitter .

Germany Respiratory Devices Market 2019-2025 - ResearchAndMarkets.com

Monday, May 25, 2020 - 1:35pm

The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancements, are the major factors augmenting the growth of respiratory device market in the country.

Key Points: 
  • The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancements, are the major factors augmenting the growth of respiratory device market in the country.
  • Market players operating in the country are adopting various strategies which are providing the needful thrust to the market growth.
  • The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories.
  • Insights about market determinants which are stimulating the Germany respiratory device market.

The Europe millets market was valued at US$ 1,327.96 million in 2018 and is expected to grow at a CAGR of 5.4% from 2019 to2027 to reach US$ 2,132.00 million by 2027

Saturday, May 23, 2020 - 2:05am

The Europe millets market was valued at US$ 1,327.96 million in 2018 and is expected to grow at a CAGR of 5.4% from 2019 to2027 to reach US$ 2,132.00 million by 2027.

Key Points: 
  • The Europe millets market was valued at US$ 1,327.96 million in 2018 and is expected to grow at a CAGR of 5.4% from 2019 to2027 to reach US$ 2,132.00 million by 2027.
  • Millets are an ideal food for people suffering from chronic diseases such as diabetes and heart diseases.
  • Regular consumption of millets helps in preventing gastrointestinal problems and other diseases related to kidney and liver.
  • Some of the players present in the Europe millets market are Just Organik, Shimla Hills Offerings Pvt.Ltd, Sresta Natural Bioproducts Pvt.

Global Ventilator Market Report 2020-2025: Featuring Profiles of Key Players Medtronic, Zoll Medical, Getinge AB, Allied Healthcare Products and Air Liquide

Friday, May 22, 2020 - 8:00pm

DUBLIN, May 22, 2020 /PRNewswire/ -- The "Ventilator Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 22, 2020 /PRNewswire/ -- The "Ventilator Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The ventilator market is projected to grow at a CAGR of 5.53% to reach US$3,095.180 million by 2025 from US$2,240.940 million in 2019.
  • The rise in cases of respiratory emergencies and Chronic Obstructive Pulmonary Disease (COPD) are the major factors, which are strengthening the growth of global ventilator market.
  • The "Ventilator Market - Forecasts from 2020 to 2025" report segments the industry as follows:

Insights into the Worldwide Digital Pathology Industry to 2025 - Featuring Leica Biosystems, Koninklijke Philips & Hamamatsu Photonics Among Others - ResearchAndMarkets.com

Wednesday, May 20, 2020 - 3:17pm

The Global Digital Pathology Market is expected to grow at a formidable rate during the forecast period.

Key Points: 
  • The Global Digital Pathology Market is expected to grow at a formidable rate during the forecast period.
  • The Global Digital Pathology Market is driven by the increasing prevalence of diseases especially chronic diseases such as cancer, diabetes, renal diseases, cancer, hepatitis, among others.
  • The Global Digital Pathology Market is segmented based on component, technology, type, application, end-user, company and region.
  • Regionally, the digital pathology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa.

Spending on Medical Services to Rise as Population Ages, Rising Incidence of Conditions

Tuesday, May 19, 2020 - 2:37pm

Providers are expected to benefit from continued growth in consumer incomes, government healthcare spending, and the number of acute and chronic conditions.

Key Points: 
  • Providers are expected to benefit from continued growth in consumer incomes, government healthcare spending, and the number of acute and chronic conditions.
  • Hospitals are expected to remain the leading provider of medical services in dollar terms due to their specialization in high-cost, complex treatments.
  • The aging of the population and the resulting growth in the number of acute and chronic conditions will continue to drive demand.
  • Spending for home healthcare services is projected to exhibit the most rapid growth among discrete expenditure segments, with expected annual increases of 7.3% to 2024.

Holmusk Announces Closing of US$21.5 Million Series A Funding Round, Led by Optum Ventures & Health Catalyst Capital

Monday, May 18, 2020 - 5:00am

The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals.

Key Points: 
  • The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals.
  • Holmusk is building the world's largest Real-World Evidence (RWE) platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions.
  • In 2016, Holmusk acquired MindLinc, an Electronic Health Record (EHR) system focused on behavioral health, from Duke University School of Medicine.
  • Dr. Vijay Barathan from Optum Ventures (OV) and Charles Boorady from Health Catalyst Capital (HCC) will be joining the Board of Directors.

Holmusk Announces Closing of US$21.5 Million Series A Funding Round, Led by Optum Ventures & Health Catalyst Capital

Monday, May 18, 2020 - 5:00am

The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals.

Key Points: 
  • The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals.
  • Holmusk is building the world's largest Real-World Evidence (RWE) platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions.
  • In 2016, Holmusk acquired MindLinc, an Electronic Health Record (EHR) system focused on behavioral health, from Duke University School of Medicine.
  • Dr. Vijay Barathan from Optum Ventures (OV) and Charles Boorady from Health Catalyst Capital (HCC) will be joining the Board of Directors.

Launch of the Chronic Pain Centre of Excellence for Canadian Veterans

Thursday, May 14, 2020 - 7:18pm

The Chronic Pain Centre of Excellence for Canadian Veterans (Centre of Excellence) is proud to announce its official launch at McMaster Universitys Faculty of Health Sciences.

Key Points: 
  • The Chronic Pain Centre of Excellence for Canadian Veterans (Centre of Excellence) is proud to announce its official launch at McMaster Universitys Faculty of Health Sciences.
  • With more than 40% of Canadian Veterans suffering from chronic pain, the Centre of Excellence will focus on pain management research and evidence-based therapies that address Veterans complex chronic pain challenges and needs.
  • Our government is proud to be working with McMaster to launch Chronic Pain Centre of Excellence for Canadian Veterans.
  • As a leader in Veteran-first chronic pain research, the Centre of Excellence is building a national network of pain clinics, researchers, and patients, to help improve the lives of Veterans and their families suffering from chronic pain.